Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival Endpoints in Randomized Clinical Trials in Sarcoma Patients: Meta-analyses for the Assessment of the Impact Various Definitions on Trials' Results and of Surrogate Properties for OS

NCT02873923 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT02873923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02873923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival Endpoints in Randomized Clinical Trials in Sarcoma Patients: Meta-analyses for the Assessment of the Impact Various Definitions on Trials' Results and of Surrogate Properties for OS
Lead sponsor
Institut Bergonié
Phase
Observational
Overall status
Completed
Start date
October 31, 2012
Completion date
January 1, 2017
Enrollment
2,846 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer